RelB is required for Peyer's patch development: Differential regulation of p52-RelB by lymphotoxin and TNF

EMBO Journal

Volumn 22, Issue 1, 2003, Pages 121-130

  Yilmaz, Z Buket ^a   Weih, Debra S ^a   Sivakumar, Vallabhapurapu ^a   Weih, Falk ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Aly; I B kinase; NF B p100 processing; Secondary lymphoid organs

Indexed keywords

DIMER; GENE PRODUCT; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 7; LYMPHOTOXIN; PROTEIN P52; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; ENZYME SUBUNIT; GENE ACTIVATION; GENE CONTROL; GENE DISRUPTION; GENE EXPRESSION; INTESTINE CELL; LYMPHOID ORGAN; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELLS, CULTURED; DNA PRIMERS; GENE EXPRESSION REGULATION; INTESTINAL MUCOSA; LYMPHOTOXIN-ALPHA; MICE; MICE, KNOCKOUT; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; PEYER'S PATCHES; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0037413709     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdg004     Document Type: Article

References (61)

1. Adachi, S., Yoshida, H., Kataoka, H. and Nishikawa, S. (1997) Three distinctive steps in Peyer's patch formation of murine embryo. Int. Immunol., 9, 507-514.
2. Adachi, S., Yoshida, H., Honda, K., Maki, K., Saijo, K., Ikuta, K., Saito, T. and Nishikawa, S.I. (1998) Essential role of IL-7 receptor α in the formation of Peyer's patch anlage. Int. Immunol., 10, 1-6.
3. Alcamo, E., Hacohen, N., Schulte, L.C., Rennert, P.D., Hynes, R.O. and Baltimore, D. (2002) Requirement for the NF-κB family member RelA in the development of secondary lymphoid organs. J. Exp. Med., 195, 233-244.
4. Attar, R.M., Caamaño, J., Carrasco, D., Iotsova, V., Ishikawa, H., Ryseck, R.-P., Weih, F. and Bravo, R. (1997) Genetic approaches to study Rel/NF-κB/IκB function in mice. Semin. Cancer Biol., 8, 93-101.
5. Barkett, M. and Gilmore, T.D. (1999) Control of apoptosis by Rel/NF-κB transcription factors. Oncogene, 18, 6910-6924.
6. Bren, G.D., Solan, N.J., Miyoshi, H., Pennington, K.N., Pobst, L.J. and Paya, C.V. (2001) Transcription of the RelB gene is regulated by NF-κB. Oncogene, 20, 7722-7733.
7. Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconi, L.A., Olson, D., Tizard, R., Cate, R. and Lo, D. (1995) Expression of relB is required for the development of thymic medulla and dendritic cells. Nature, 373, 531-536.
8. Caamaño, J.H., Rizzo, C.A., Durham, S.K., Barton, D.S., Raventos-Suarez, C., Snapper, C.M. and Bravo, R. (1998) Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med., 187, 185-196.
9. Debard, N., Sierro, F. and Kraehenbuhl, J.P. (1999) Development of Peyer's patches, follicle-associated epithelium and M cell: lessons from immunodeficient and knockout mice. Semin. Immunol., 11, 183-191.
10. Dobrzanski, P., Ryseck, R.-P. and Bravo, R. (1994) Differential interaction of Rel/NF-κB complexes with IκBα determine pools of constitutive and inducible NF-κB activity. EMBO J., 13, 4608-4616.
11. Dobrzanski, P., Ryseck, R.-P. and Bravo, R. (1995) Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. Oncogene, 10, 1003-1007.
12. Franzoso, G. et al. (1998) Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions and splenic microarchitecture. J. Exp. Med., 187, 147-159.
13. Fu, Y.-X. and Chaplin, D.D. (1999) Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol., 17, 399-433.
14. Fütterer, A., Mink, K., Luz, A., Kosco-Vilbois, M.H. and Pfeffer, K. (1998) The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity, 9, 59-70.
15. Gerondakis, S., Grossmann, M., Nakamura, Y., Pohl, T. and Grumont, R. (1999) Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts. Oncogene, 18, 6888-6895.
16. Ghosh, S., May, M.J. and Kopp, E.B., (1998) NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol., 16, 225-260.
17. Griebel, P.J. and Hein, W.R. (1996) Expanding the role of Peyer's patches in B-cell ontogeny. Immunol. Today, 17, 30-39.
18. Hamada, H. et al. (2002) Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J. Immunol., 168, 57-64.
19. Hashi, H. et al. (2001) Compartmentalization of Peyer's patch anlagen before lymphocyte entry. J. Immunol., 166, 3702-3709.
20. Hatada, E.N., Krappmann, D. and Scheidereit, C. (2000) NF-κB and the innate immune response. Curr. Opin. Immunol., 12, 52-58.
21. Hogan, B., Beddington, R., Costantini, F. and Lacy, E. (1994) Preparing mouse embryo fibroblasts. In Manipulating the Mouse Embryo. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 260-261.
22. Honda, K. et al. (2001) Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J. Exp. Med., 193, 621-630.
23. Ishikawa, H., Carrasco, D., Claudio, E., Ryseck, R.-P. and Bravo, R. (1997) Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-κB2. J. Exp. Med., 186, 999-1014.
24. Ishikawa, H., Claudio, E., Dambach, D., Raventos-Suarez, C., Ryan, C. and Bravo, R. (1998) Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-κB1) but expressing p50. J. Exp. Med., 187, 985-996.
25. Karin, M. and Ben-Neriah, Y. (2000) Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol., 18, 621-663.
26. Karin, M. and Delhase, M. (2000) The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling. Semin. Immunol., 12, 85-98.
27. Karin, M. and Lin, A. (2002) NF-κB at the crossroads of life and death. Nat. Immunol., 3, 221-227.
28. Karin, M., Cao, Y., Greten, F.R. and Li, Z.W. (2002) NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer, 2, 301-310.
29. 1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol. Cell. Biol., 11, 2451-2459.
30. Lernbecher, T., Kistler, B. and Wirth, T. (1994) Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J., 13, 4060-4069.
31. Ling, L., Cao, Z. and Goeddel, D.V. (1998) NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc. Natl Acad. Sci. USA, 95, 3792-3797.
32. Mackay, F., Majeau, G.R., Hochman, P.S. and Browning, J.L. (1996) Lymphotoxin β receptor triggering induces activation of the nuclear factor κB transcription factor in some cell types. J. Biol. Chem., 271, 24934-24938.
33. Matsumoto, M. (1999) Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting. J. Med. Invest., 46, 141-150.
34. Matsushima, A., Kaisho, T., Rennert, P.D., Nakano, H., Kurosawa, K., Uchida, D., Takeda, K., Akira, S. and Matsumoto, M. (2001) Essential role of nuclear factor (NF)-κB-inducing kinase and inhibitor of κB (IκB) kinase α in NF-κB activation through lymphotoxin β receptor, but not through tumor necrosis factor receptor I. J. Exp. Med., 193, 631-636.
35. Mercurio, F., DiDonato, J.A., Rosette, C. and Karin, M. (1993) p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev., 7, 705-718.
36. Miyawaki, S., Nakamura, Y., Suzuka, H., Koba, M., Yasumizu, R., Ikehara, S. and Shibata, Y. (1994) A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur. J. Immunol., 24, 429-434.
37. Naumann, M. and Scheidereit, C. (1994) Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J., 13, 4597-4607.
38. Nishikawa, S., Honda, K., Hashi, H. and Yoshida, H. (1998) Peyer's patch organogenesis as a programmed inflammation: a hypothetical model. Cytokine Growth Factor Rev., 9, 213-220.
39. Pahl, H.L. (1999) Activators and target genes of Rel/NF-κB transcription factors. Oncogene, 18, 6853-6866.
40. Pasparakis, M., Alexopoulou, L., Grell, M., Pfizenmaier, K., Bluethmann, H. and Kollias, G. (1997) Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor. Proc. Natl Acad. Sci. USA, 94, 6319-6323.
41. Paxian, S., Merkle, H., Riemann, M., Wilda, M., Adler, G., Hameister, H., Liptay, S., Pfeffer, K. and Schmid, R.M. (2002) Abnormal organogenesis of Peyer's patches in mice deficient for NF-κB1, NF-κB2 and Bcl-3. Gastroenterology, 122, 1853-1868.
42. Pfeffer, K. et al. (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell, 73, 457-467.
43. Poljak, L., Carlson, L., Cunningham, K., Kosco-Vilbois, M.H. and Siebenlist, U. (1999) Distinct activities of p52/NF-κB required for proper secondary lymphoid organ microarchitecture: functions enhanced by Bcl-3. J. Immunol., 163, 6581-6588.
44. Rennert, P.D., James, D., Mackay, F., Browning, J.L. and Hochman, P.S. (1998) Lymph node genesis is induced by signaling through the lymphotoxin β receptor. Immunity, 9, 71-79.
45. Ryseck, R.-P., Weih, F., Carrasco, D. and Bravo, R. (1996) RelB, a member of the Rel/NF-κB family of transcription factors. Braz. J. Med. Biol. Res., 29, 895-903.
46. Schreiber, E., Matthias, P., Müller, M.M. and Schaffner, W. (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res., 17, 6419.
47. Senftleben, U. et al. (2001) Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science, 293, 1495-1499.
48. Sha, W.C., Liou, H.-C., Tuomanen, E.I. and Baltimore, D. (1995) Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell, 80, 321-330.
49. Shinkura, R., Kitada, K., Matsuda, F., Tashiro, K., Ikuta, K., Suzuki, M., Kogishi, K., Serikawa, T. and Honjo, T. (1999) Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-κB-inducing kinase. Nat. Genet., 22, 74-77.
50. Smith, C., Andreakos, E., Crawley, J.B., Brennan, F.M., Feldmann, M. and Foxwell, B.M. (2001) NF-κB-inducing kinase is dispensable for activation of NF-κB in inflammatory settings but essential for lymphotoxin β receptor activation of NF-κB in primary human fibroblasts. J. Immunol., 167, 5895-5903.
51. Solan, N.J., Miyoshi, H., Carmona, E.M., Bren, G.D. and Paya, C.V. (2002) RelB cellular regulation and transcriptional activity are regulated by p100. J. Biol. Chem., 277, 1405-1418.
52. Vallabhapurapu, S., Ryseck, R.-P., Malewicz, M., Weih, D.S. and Weih, F. (2001) Inhibition of NF-κB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld/gld mice. Eur. J. Immunol., 31, 2612-2622.
53. VanArsdale, T.L., VanArsdale, S.L., Force, W.R., Walter, B.N., Mosialos, G., Kieff, E., Reed, J.C. and Ware, C.F. (1997) Lymphotoxin-β receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB. Proc. Natl Acad. Sci. USA, 94, 2460-2465.
54. Weih, D.S., Yilmaz, Z.B. and Weih, F. (2001) Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. Immunol., 167, 1909-1919.
55. Weih, F., Carrasco, D. and Bravo, R. (1994) Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene, 9, 3289-3297.
56. Weih, F., Carrasco, D., Durham, S.K., Barton, D.S., Rizzo, C.A., Ryseck, R.-P., Lira, S.A. and Bravo, R. (1995) Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell, 80, 331-340.
57. Weih, F., Warr, G., Yang, H. and Bravo, R. (1997) Multifocal defects in immune responses in RelB-deficient mice. J. Immunol., 158, 5211-5218.
58. Xiao, G., Harhaj, E.W. and Sun, S.-C. (2001) NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell, 7, 401-409.
59. Yin, L., Wu, L., Wesche, H., Arthur, C.D., White, J.M., Goeddel, D.V. and Schreiber, R.D. (2001) Defective lymphotoxin-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice. Science, 291, 2162-2165.
60. Yokota, Y., Mansouri, A., Mori, S., Sugawara, S., Adachi, S., Nishikawa, S. and Gruss, P. (1999) Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature, 397, 702-706.
61. - cells in the embryonic intestine induce the organizing center of Peyer's patches. Int. Immunol., 11, 643-655.